NP Life Sciences Health Industry Group Inc. Quarterly Debt-to-equity in % from Q2 2020 to Q3 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
NP Life Sciences Health Industry Group Inc. quarterly Debt-to-equity history and growth rate from Q2 2020 to Q3 2023.
  • NP Life Sciences Health Industry Group Inc. Debt-to-equity for the quarter ending September 30, 2023 was 267 %, a 266% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2023 267 +194 +266% Sep 30, 2023
Q2 2023 293 +216 +279% Jun 30, 2023
Q1 2023 500 +434 +665% Mar 31, 2023
Q4 2022 401 +372 +1285% Dec 31, 2022
Q3 2022 73.2 +46.3 +172% Sep 30, 2022
Q2 2022 77.5 +58.2 +301% Jun 30, 2022
Q1 2022 65.3 +49 +300% Mar 31, 2022
Q4 2021 28.9 +13.7 +90.4% Dec 31, 2021
Q3 2021 26.9 +14.4 +115% Sep 30, 2021
Q2 2021 19.3 +11 +131% Jun 30, 2021
Q1 2021 16.3 Mar 31, 2021
Q4 2020 15.2 Dec 31, 2020
Q3 2020 12.5 Sep 30, 2020
Q2 2020 8.34 Jun 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.